These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 30126257)

  • 1. Deubiquitinating Enzymes Related to Autophagy: New Therapeutic Opportunities?
    Jacomin AC; Taillebourg E; Fauvarque MO
    Cells; 2018 Aug; 7(8):. PubMed ID: 30126257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-Related Deubiquitinating Enzymes Involved in Health and Disease.
    Magraoui FE; Reidick C; Meyer HE; Platta HW
    Cells; 2015 Oct; 4(4):596-621. PubMed ID: 26445063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases.
    Seiberlich V; Goldbaum O; Zhukareva V; Richter-Landsberg C
    Biochim Biophys Acta; 2012 Nov; 1823(11):2057-68. PubMed ID: 22565157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Deubiquitinating Enzymes in the Various Forms of Autophagy.
    Csizmadia T; Lőw P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy/Mitophagy Regulated by Ubiquitination: A Promising Pathway in Cancer Therapeutics.
    Jee SC; Cheong H
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein deubiquitination by PR-619 activates the autophagic pathway in OLN-t40 oligodendroglial cells.
    Seiberlich V; Borchert J; Zhukareva V; Richter-Landsberg C
    Cell Biochem Biophys; 2013 Sep; 67(1):149-60. PubMed ID: 23686611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
    Mooneyham A; Bazzaro M
    Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal Mitophagy in Neurodegenerative Diseases.
    Martinez-Vicente M
    Front Mol Neurosci; 2017; 10():64. PubMed ID: 28337125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.
    Do HA; Baek KH
    Ageing Res Rev; 2021 Aug; 69():101367. PubMed ID: 34023421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating autophagy and mitophagy as a promising therapeutic approach in neurodegenerative disorders.
    Mishra J; Bhatti GK; Sehrawat A; Singh C; Singh A; Reddy AP; Reddy PH; Bhatti JS
    Life Sci; 2022 Dec; 311(Pt A):121153. PubMed ID: 36343743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinating Enzymes in Parkinson's Disease.
    Chakraborty J; Ziviani E
    Front Physiol; 2020; 11():535. PubMed ID: 32581833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
    Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
    Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective autophagy: The new player in the fight against neurodegenerative diseases?
    Wu MY; Song JX; Wang SF; Cai CZ; Li M; Lu JH
    Brain Res Bull; 2018 Mar; 137():79-90. PubMed ID: 29155260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
    Jin WL; Mao XY; Qiu GZ
    Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
    Poondla N; Chandrasekaran AP; Kim KS; Ramakrishna S
    BMB Rep; 2019 Mar; 52(3):181-189. PubMed ID: 30760385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and mitophagy interplay in melanoma progression.
    Maes H; Agostinis P
    Mitochondrion; 2014 Nov; 19 Pt A():58-68. PubMed ID: 25042464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting deubiquitinating enzymes in cancer stem cells.
    Lei H; Shan H; Wu Y
    Cancer Cell Int; 2017; 17():101. PubMed ID: 29142505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Autophagy as a Potential Therapeutic Target in Age-Associated Pathologies.
    Papandreou ME; Tavernarakis N
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover.
    Palikaras K; Daskalaki I; Markaki M; Tavernarakis N
    Pharmacol Ther; 2017 Oct; 178():157-174. PubMed ID: 28461251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of autophagy by histone-modifying enzymes under nutrient stress.
    Yu YS; Kim H; Kim KI; Baek SH
    Cell Death Differ; 2023 Jun; 30(6):1430-1436. PubMed ID: 36997734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.